SNS-103
sensei biotherapeutics
['$snse', 'sensei']
$snse sensei biotherapeutics shares promising preclinical data on sns-103 at aacr 2023 targeting entpdase1 (cd39). more info: $xbi $ibb $xph $pph
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT